Dr Charles Heard
Prosiectau fel Prif Ymchwiliwr
- Design, synthesis and evaluation of novel agents to treat retinal blinding disease, Leber's congenital amaurosis (01.09.2015 - 30.11.2016)
- Determining in vitro whether magnesium penetrates skin (01.07.2011 - 30.09.2011)
- Evaluation of buccal spray products (01.10.2018 - 30.04.2019)
- Formulation effects in anti-microbial activity - Nor Hayati Binti Abu Samah (01.10.2007 - 30.09.2010)
- Improved individual protection from airbourne viruses using masks containing natural biocide-impregnated filters (01.11.2013 - 31.07.2014)
Prosiectau fel Cyd-Ymchwiliwr
- Repurposing AMPA/kainite glutamate receptor antagonists for prevention of injury-induced osteoarthritis (01.09.2016 - 28.02.2017)
- Role photosensitizing components of Burch's membrane in age-related macular degeneration (AMD) and therapeutic strategy to counteract their deleterious effects (31.01.2016 - 31.12.2016)
- Sustained release formulations for new drugs in the treatment of mitochondrial optic neuropathies (01.02.2020 - 11.02.2022)
- Targeted drug delivery to the cornea of the eye via medicated contact lenses and mucoadhesive thin films (01.02.2019 - 28.12.2022)
- Targeted drug delivery to the cornea of the eye via thin-film slow release technology (01.05.2017 - 31.08.2018)